Background: Electronic health records are becoming an increasingly valuable resource for epidemiology but their data quality needs to be quantified. We aimed to validate twenty-five types of incident ...cancer cases in the Information System for Research in Primary Care (SIDIAP) in Catalonia with the population-based cancer registries of Girona and Tarragona as the gold-standard. Methods: We calculated the sensitivity, positive predictive values (PPV), and the time-difference between the date of diagnosis entered into the SIDIAP and into the registries. We added hospital discharge cancer diagnoses to the SIDIAP to assess sensitivity changes. Results: We identified 27,046 incident cancer diagnoses in the SIDIAP from 2009-2015 among the 949,841 residents of Girona and Tarragona. The cancer types with the highest sensitivity were breast (89%, 95% CI: 88-90%), colorectal (81%, 95% CI: 80-82%), and prostate (81%, 95% CI: 80-83%). Trachea, bronchus and lung cancers had the highest PPV (76%, 95% CI: 74%-78%) followed by stomach (72%, 95% CI: 68-75%) and pancreas (71%, 95% CI: 67-75%). Most cancer diagnoses were reported with less than three months of difference between the SIDIAP and the registries. More cases were registered first in the registries than in the SIDIAP. By adding cancer diagnoses based on hospital discharge data, sensitivity increased for all cancers, especially for gallbladder and biliary tract for which the sensitivity increased by 21%. Conclusion: The SIDIAP includes 76% of the cancer diagnoses in the cancer registries but includes a considerable number of cases that are not in the registries. The SIDIAP reports most of the cancer diagnoses within a three-month period difference from the date of diagnosis in the cancer registries. Our results support the use of the SIDIAP cancer diagnoses for epidemiological research when cancer is the outcome of interest. We recommend adding hospital discharge data to the SIDIAP to increase data quality, particularly for less frequent cancer types. Keywords: validation studies, cancer, electronic health records, primary health care, population-based cancer registries
We aimed to assess the feasibility of TESTA'T COVID strategy among healthcare and education professionals.in Spain during the peak of the 6.sup.th wave caused by Omicron variant. Kits were ordered ...online and sent by mail, participants answered an online acceptability/usability survey and uploaded the picture of results. 492 participants ordered a test, 304 uploaded the picture (61.8%). Eighteen positive cases were detected (5.9%). 92.2% were satisfied/very satisfied with the intervention; and 92.5% found performing the test easy/very easy. We demonstrated that implementing online COVID-19 self-testing in schools and healthcare settings in Spain is feasible.
La presente investigación busca aproximarse a las causas y consecuencias del cyberbullying, respecto a la ideación suicida, en el escenario escolar, caracterizado por ser un fenómeno que afecta el ...ámbito escolar puesto que se trata de una etapa del ciclo vital donde las cybervíctimas experimentan sentimientos de inferioridad, miedo, ansiedad, estrés e ideas suicidas, entre otras. De este modo, el objetivo de la investigación fue identificar si existen ideas suicidas en jóvenes víctimas de cyberbullying. En este estudio participaron 397 estudiantes de la Institución Nuestra Señora del Pilar de la ciudad de Bucaramanga, con edades comprendidas entre los 10 y 20 años (63.7% mujeres y 36.3% hombres), haciendo uso de la escala la Escala de Ideación Suicida de Beck y el Cuestionario de cyberbullying de Ortega, Calmaestra y Mora-Merchán. Así mismo, a través del estudio bibliográfico y los resultados obtenidos de las pruebas se logra evidenciar que el ciberacoso tiene una relación directa con actitudes, intentos y pensamientos suicidas, encontrando que nuestros resultados concuerdan con la literatura, donde se afirma que las mujeres son más propensas a sufrir el acoso, mientras que los hombres son más tendentes a ejercerlo.
The COVID-19 pandemic disrupted healthcare services usage. We estimated the impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV (PLWH) in Catalonia, Spain.
...We accessed public healthcare usage in HIV units, primary care, hospitals, and emergency departments among 17,738 PLWH in the PISCIS cohort from January 1, 2017, to December 31, 2020. We performed an interrupted time series analysis using the autoregressive integrated moving average to estimate the effect of COVID-19 on medical visits and HIV monitoring among PLWH.
A non-significant decrease of 17.1% (95% CI: −29.4, 0.4) in overall medical visits was observed during the lockdown, followed by a steady resumption until the end of 2020. Three health facilities presented statistically significant declines in visits during the lockdown: HIV units (−44.8% −56.7, −23.6), hospitals (−40.4% −52.8, −18.1), and emergency departments (−36.9% −47.0, −21.9); thereafter, the visits have begun to increase steadily but not to previous levels as of December 2020. In contrast, primary care visits remained unchanged during the lockdown by 1.9% (95% CI: −13.5, 23.9). CD4 cell (54.2% 95% CI: −64.4, −36.0) and HIV RNA viral load (53.1% 95% CI: −62.9, −36.1) laboratory monitoring reduced significantly during the lockdown.
COVID-19 lockdowns significantly disrupted in-person healthcare services usage among PLWH. The reduction in healthcare utilization however did not affect primary care services. Despite services gradually rebounding to pre-pandemic levels, it is imperative to effectively prepare for future pandemics and implement measures to ensure continuous provision of care to PLWH during pandemic lockdowns.
La pandemia de COVID-19 interrumpió el uso de los servicios sanitarios. Estimamos el impacto de la pandemia de COVID-19 en la utilización de los servicios de salud entre las personas que viven con el VIH (PVV) en Cataluña, España.
Registramos el uso de la atención médica pública en unidades de VIH, atención primaria, hospitales y centros de urgencias en 17.738PVV de la cohorte PISCIS desde el 1 de enero de 2017 hasta el 31 de diciembre de 2020. Realizamos un análisis de series temporales interrumpidas utilizando el promedio móvil integrado autorregresivo para estimar el efecto de la COVID-19 en las consultas médicas y el seguimiento del VIH entre las PVV.
Se observó una disminución no significativa del 17,1% (IC95%: −29,4 a 0,4) en las visitas médicas generales durante el confinamiento, seguida de una reanudación constante hasta finales de 2020. Tres establecimientos de salud presentaron disminuciones estadísticamente significativas en las visitas durante el confinamiento: unidades de VIH (−44,8% −56,7 a −23,6), hospitales (−40,4% −52,8 a −18,1) y urgencias (−36,9% −47,0 a −21,9); a partir de entonces, las visitas han comenzado a aumentar de manera constante, pero no a los niveles anteriores a diciembre de 2020. Por el contrario, las visitas de atención primaria se mantuvieron sin cambios durante el confinamiento en un 1,9% (ICIC 95%: −13,5 a 23,9). El control de las analíticas de células CD4 (54,2% IC95%: −64,4 a −36,0) y de la carga viral de ARN del VIH (53,1% IC95%: −62,9 a −36,1) se redujo significativamente durante el confinamiento.
Los bloqueos de COVID-19 interrumpieron significativamente el uso de servicios de atención médica en persona entre las PVV. Sin embargo, la reducción en la utilización de la atención sanitaria no afectó a los servicios de atención primaria. A pesar de que los servicios se recuperan gradualmente a los niveles previos a la pandemia, es imperativo prepararse de manera efectiva para futuras pandemias e implementar medidas para garantizar la provisión continua de atención a las PVV durante los bloqueos por pandemia.
It is unclear if SARS-CoV-2 has affected people living with HIV (PLWH) more.
We compared SARS-CoV-2 testing, test positivity, hospitalisation, intensive care unit (ICU) admission, and mortality ...between PLWH and the general HIV-negative population of Catalonia, Spain from March 1 to December 15, 2020.
SARS-CoV-2 testing was lower among PLWH 3556/13,142 (27.06%) compared to the general HIV-negative population 1,954,902/6,446,672 (30.32%) (p<0.001) but test positivity was higher among PLWH (21.06% vs. 15.82%, p<0.001). We observed no significant differences between PLWH and the general population in terms of hospitalisation (13.75% vs. 14.97%, p=0.174) and ICU admission (0.93% vs. 1.66%, p=0.059). Among positive cases, we found a lower mortality rate among PLWH compared to the general population (1.74% vs 3.64%, p=0.002).
PLWH tested less frequently for SARS-CoV-2, had a higher test positivity, similar ICU admission and hospitalisation rates, and lower SARS-CoV-2-associated mortality compared to the general HIV-negative population.
No está claro si el SARS-CoV-2 ha afectado más a las personas que viven con VIH (PVV).
Se compararon los test realizados de SARS-CoV-2, la positividad de la prueba, la hospitalización, los ingresos en la unidad de cuidados intensivos (UCI), las tasas de mortalidad entre PVV y la población general de Cataluña desde el 1 de marzo hasta el 15 de diciembre de 2020.
Los test realizados de SARS-CoV-2 fueron menos entre PVV 3.556/13.142 (27.06%) comparado con la población general de Cataluña 1.954.902/6.446.672 (30,32%) (p<0,001), pero la positividad de la prueba de SARS-CoV-2 fue mayor entre las PVV (21,06 vs. 15,82%; p<0,001). No se observaron diferencias estadísticamente significativas entre PVV y la población general en cuanto a hospitalizaciones (13,75 vs. 14,97%; p=0,174) e ingresos en la UCI (0,93 vs. 1,66%; p=0,059). Entre los casos positivos, se encontró una menor tasa de mortalidad entre las PVV en comparación con la población general (1,74 vs. 3,64%; p=0,002).
Las PVV fueron testadas menos frecuentemente por SARS-CoV-2 que la población general, tuvieron una tasa de positividad más elevada, tasas similares de hospitalización e ingresos en la UCI, y menos mortalidad asociada al SARS-CoV-2.
The COVID-19 pandemic disrupted healthcare services usage. We estimated the impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV (PLWH) in Catalonia, Spain.
...We accessed public healthcare usage in HIV units, primary care, hospitals, and emergency departments among 17,738 PLWH in the PISCIS cohort from January 1, 2017, to December 31, 2020. We performed an interrupted time series analysis using the autoregressive integrated moving average to estimate the effect of COVID-19 on medical visits and HIV monitoring among PLWH.
A non-significant decrease of 17.1% (95% CI: -29.4, 0.4) in overall medical visits was observed during the lockdown, followed by a steady resumption until the end of 2020. Three health facilities presented statistically significant declines in visits during the lockdown: HIV units (-44.8% -56.7, -23.6), hospitals (-40.4% -52.8, -18.1), and emergency departments (-36.9% -47.0, -21.9); thereafter, the visits have begun to increase steadily but not to previous levels as of December 2020. In contrast, primary care visits remained unchanged during the lockdown by 1.9% (95% CI: -13.5, 23.9). CD4 cell (54.2% 95% CI: -64.4, -36.0) and HIV RNA viral load (53.1% 95% CI: -62.9, -36.1) laboratory monitoring reduced significantly during the lockdown.
COVID-19 lockdowns significantly disrupted in-person healthcare services usage among PLWH. The reduction in healthcare utilization however did not affect primary care services. Despite services gradually rebounding to pre-pandemic levels, it is imperative to effectively prepare for future pandemics and implement measures to ensure continuous provision of care to PLWH during pandemic lockdowns.
PDF
